Color blindness
|
0.010 |
Biomarker
|
disease |
BEFREE |
One of the normal families was segregating for protan colour blindness and showed a phase known recombination which would support the order centromere--F9--DXS52--CBP--Xqter.
|
2879932 |
1987 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Targeting the transcriptional cofactors (CBP, etc) by EWS-fusion proteins could be one of the mechanisms of activation of EWS-fusion proteins in human neoplasia.
|
8552387 |
1996 |
Adenovirus Infections
|
0.010 |
Biomarker
|
group |
BEFREE |
Our results suggest that the p300/CBP-binding domain of E1A inhibits a p53-dependent cellular response which normally inhibits DNA replication following Adenovirus infection.
|
9070653 |
1997 |
Childhood Myelodysplastic Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The t(11;16)(q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene.
|
9166831 |
1997 |
MYELODYSPLASTIC SYNDROME
|
0.010 |
GeneticVariation
|
group |
BEFREE |
The t(11;16)(q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene.
|
9166831 |
1997 |
Adult Myelodysplastic Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The t(11;16)(q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene.
|
9166831 |
1997 |
Leukemia, Myelocytic, Acute
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Intriguingly, mutations in the CBP gene are responsible for RTS as well as the t(8;16)-associated AML.
|
9177780 |
1997 |
Rothmund-Thomson syndrome
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
Intriguingly, mutations in the CBP gene are responsible for RTS as well as the t(8;16)-associated AML.
|
9177780 |
1997 |
Rett Syndrome
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
Intriguingly, mutations in the CBP gene are responsible for RTS as well as the t(8;16)-associated AML.
|
9177780 |
1997 |
Treatment related acute myeloid leukaemia
|
0.050 |
Biomarker
|
disease |
BEFREE |
The CBP gene was recently identified as a partner gene in the t(8;16) that occurs in acute myelomonocytic leukemia (AML-M4) de novo and rarely in treatment-related acute myeloid leukemia.
|
9226152 |
1997 |
Acute myelomonocytic leukemia
|
0.030 |
Biomarker
|
disease |
BEFREE |
The CBP gene was recently identified as a partner gene in the t(8;16) that occurs in acute myelomonocytic leukemia (AML-M4) de novo and rarely in treatment-related acute myeloid leukemia.
|
9226152 |
1997 |
Hematological Disease
|
0.010 |
Biomarker
|
group |
BEFREE |
All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders.
|
9226152 |
1997 |
Leukemogenesis
|
0.080 |
Biomarker
|
disease |
BEFREE |
CBP is the first partner gene of MLL containing well defined structural and functional motifs that provide unique insights into the potential mechanisms by which these translocations contribute to leukemogenesis.
|
9238046 |
1997 |
leukemia
|
0.070 |
Biomarker
|
disease |
BEFREE |
Both fusion products retain the histone acetyltransferase domain of CBP and may lead to leukemia by promoting histone acetylation of genomic regions targeted by the MLL AT-hooks, leading to transcriptional deregulation via aberrant chromatin organization.
|
9238046 |
1997 |
Treatment related acute myeloid leukaemia
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3).
|
9238046 |
1997 |
Childhood Leukemia
|
0.040 |
Biomarker
|
disease |
BEFREE |
Both fusion products retain the histone acetyltransferase domain of CBP and may lead to leukemia by promoting histone acetylation of genomic regions targeted by the MLL AT-hooks, leading to transcriptional deregulation via aberrant chromatin organization.
|
9238046 |
1997 |
Malignant Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
CBP and p300 have properties of tumor suppressor proteins; their interaction with P/CAF is disrupted by the adenoviral E1A oncoprotein, and the genes encoding CBP and p300 are mutated in human cancer.
|
9288775 |
1997 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
CBP and p300 have properties of tumor suppressor proteins; their interaction with P/CAF is disrupted by the adenoviral E1A oncoprotein, and the genes encoding CBP and p300 are mutated in human cancer.
|
9288775 |
1997 |
Primary malignant neoplasm
|
0.100 |
Biomarker
|
group |
BEFREE |
CBP and p300 have properties of tumor suppressor proteins; their interaction with P/CAF is disrupted by the adenoviral E1A oncoprotein, and the genes encoding CBP and p300 are mutated in human cancer.
|
9288775 |
1997 |
Leukemia, Myelocytic, Acute
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
CBP, which is located on 16p13 and encodes a transcriptional adaptor/coactivator protein, has been shown to fuse by the t(8;16)(p11;p13) translocation to MOZ on 8p11 in acute myeloid leukemia.
|
9290955 |
1997 |
leukemia
|
0.070 |
GeneticVariation
|
disease |
BEFREE |
Because 11q23 translocations involving MLL and t(8;16) involving MOZ and CBP have been reported in therapy-related leukemias, both the MLL and CBP genes may be targets for topoisomerase II inhibitors.
|
9290955 |
1997 |
Leukemia, Myelomonocytic, Chronic
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Novel MLL-CBP fusion transcript in therapy-related chronic myelomonocytic leukemia with a t(11;16)(q23;p13) chromosome translocation.
|
9290955 |
1997 |
Juvenile Myelomonocytic Leukemia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Novel MLL-CBP fusion transcript in therapy-related chronic myelomonocytic leukemia with a t(11;16)(q23;p13) chromosome translocation.
|
9290955 |
1997 |
Leukemia, Myelocytic, Acute
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Detection of CBP rearrangements in acute myelogenous leukemia with t(8;16).
|
9447825 |
1997 |
Rothmund-Thomson syndrome
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
The gene for the human CREB binding protein, the transcriptional coactivator CBP, is included in the RT1 cosmid, and mutations in CBP have recently been identified in nondeleted RTS patients.
|
9677064 |
1998 |